HC Wainwright & Co. Reiterates Buy on Context Therapeutics, Maintains $4 Price Target
HC Wainwright & Co. analyst Emily Bodnar reiterates Context Therapeutics (NASDAQ:CNTX) with a Buy and maintains $4 price target.
Tesla, Amazon, Apple, Context Therapeutics, Snap: Why These 5 Stocks Are Drawing Investors’ Attention Today
Major Wall Street indices closed over 1% higher on Tuesday, led by upbeat corporate earnings and expectations that the Federal Reserve will slow down its rate hike pace as the centr
Dow Surges Over 200 Points; Pfizer Issues Weak Forecast
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Tuesday.
The Dow traded up 0.63% to 33,931.13 while the NASDAQ rose 1.20% to 11,529.99. The S&P 500 also rose, gaining, 0.93% to 4,055.00.
Why Context Therapeutics (CNTX) Shares Are Seeing Blue Skies
Context Therapeutics Inc (NASDAQ: CNTX) shares are trading higher by 60.32% to $1.10 Tuesday afternoon after the company announced its clinical trial collaborator, Stemline Therapeutics, received approval from the FDA for ORSERDU in ER+, HER2-, ESR1-mutated breast cancer.
Dow Turns Higher; Nasdaq Jumps 100 Points
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Tuesday.
The Dow traded up 0.19% to 33,781.23 while the NASDAQ rose 0.90% to 11,496.13. The S&P 500 also rose, gaining, 0.56% to 4,040.22.
Myomo, Enzo Biochem And These 2 Stocks Under $2 Insiders Are Aggressively Buying
The Dow Jones closed lower by more than 600 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Why Express Shares Are Trading Higher By 39%? Here Are 50 Stocks Moving In Thursday’s Mid-Day Session
Gainers
My Size, Inc. (NASDAQ: MYSZ) shares jumped 88% to $0.2839. My Size announced a 1-for-25 reverse stock split.
Why Context Therapeutics Stock Is Falling 25% Today
Context Therapeutics Inc (NASDAQ: CNTX) shares are trading lower by 26.62% to $1.02 during Thursday's session after the company reported preliminary Phase 2 data for ONA-XR metastatic breast cancer.
What Else?